Cancer is a dreaded diagnosis, and the treatment doesn’t give much hope. The last statistics I looked at showed major cancer hospitals having a .25% success rate. Also, cancer is one of the fastest growing causes of mortality in the world. New research on ivermectin is showing promise as a standalone drug and as an add-on to chemo protocols.
Ivermectin is normally used as an anti-parasitic drug. You may have initially heard of it as an alternative measure in the recent pandemic. The first reports of cancer use were seen in research in 1995.
- Dr. Alfonso Duenas-Gonzales says that there are4 9 perfectly defined cancer targets.
- A Japanese study looked at lung, bone and breast cancers, and found that adding ivermectin to the protocol showed enhanced results.
- Dr. Peter P. Lee has done research with ivermectin and breast cancer.
- Dr. Martin Gleave’s research shows that ivermectin inhibits HSP27, which is a stress protein that is released after chemo and radiation therapies.
Research shows that ivermectin is beneficial for these cancers:
- Prostate
- Kidney
- Esophageal
- Breast
- Ovarian
- Lung
- Glioblastoma
- Stomach
- Colon
- Liver
- Lymphoma
- Uterus
- Pancreas and
Ivermectin inhibits cancer growth by changing its mitochondrial function, blocking its ability to grow new blood vessels, and damaging the cancer’s DNA.
Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin – PMC (nih.gov)
Ivermectin and Pembrolizumab for the Treatment of Metastatic Triple Negative Breast Cancer – NCI
Until next time,
Dr. Polly
Your passion for what you do shines through in every post It’s truly inspiring to see someone doing what they love and excelling at it
Thank you so much!